©The Author(s) 2025.
World J Crit Care Med. Sep 9, 2025; 14(3): 105428
Published online Sep 9, 2025. doi: 10.5492/wjccm.v14.i3.105428
Published online Sep 9, 2025. doi: 10.5492/wjccm.v14.i3.105428
Table 4 Viral etiology concerning mortality and survival rate
| Viral serology | Outcome, n (%) | P value | |
| Died (n = 70) | Survived (n = 32) | ||
| AIH | 0.001a | ||
| Yes | - | 6 (18.8) | |
| No | 70 (100) | 26 (81.3) | |
| Anti-HAV IgM | 0.002a | ||
| Reactive | 19 (27.1) | - | |
| Non-Reactive | 51 (72.9) | 32 (100) | |
| HBs Ag | 0.173 | ||
| Reactive | 6 (8.6) | - | |
| Non-Reactive | 64 (91.4) | 32 (100) | |
| HBc IgM | 0.95 | ||
| Reactive | 7 (10) | - | |
| Non-reactive | 63 (90) | 32 (100) | |
| HEV IgM | 0.000a | ||
| Reactive | 51 (72.9) | 32 (100) | |
| Non-Reactive | 19 (27.1) | - | |
| Anti-HCV Ab | 0.105 | ||
| Reactive | 6 (8.6) | 7 (21.9) | |
| Non-reactive | 64 (91.4) | 25 (78.1) | |
- Citation: Butt N, Ali S, Khemani H, Mumtaz K. Acute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi. World J Crit Care Med 2025; 14(3): 105428
- URL: https://www.wjgnet.com/2220-3141/full/v14/i3/105428.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v14.i3.105428